CoreMedica Implements ROCHE EUA Authorized Antibody Test for COVID-19 June 12, 2020 — Lee’s Summit, MO. CoreMedica Laboratories, Inc., announced today the implementation of the Roche Elecsys Anti-SARS-CoV-2 antibody
Blood Testing Made Simple
Micro Blood Sample Collection and Analysis.
Innovation making blood testing simple. We believe access to quality, lab based testing should not only be possible through traditional venipuncture methods but also through non-invasive fingerstick methods. Our innovations in capillary blood analysis provides the best of both, a venipuncture like test menu from a fingerstick collection. Developing meaningful and deep-seated relationships with our partners is our path to success. This depth directs our development strategies and drives mutual satisfaction. Our mission ensures we’re bringing solutions that fit the specific needs of our partners so it is more than “just putting the customer first”.
Unmatched accomplishments in micro testing of wet and dried blood samples.
Innovative blood collection devices for self and professional collection.
Customizable delivery options with full integration support.
Dr. Kevin Latinis, MD, PhD. with CoreMedica’s Christina Pierce, on site at Cass County hotspot doing COVID-19 Antibody testing blood collection. CoreMedica Providing COVID-19 Antibody Testing